Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for…
Author: admin
Ingenovis Health to Acquire HealthCare Support
– Ingenovis Health, Inc. (“Ingenovis” or the “Company”), a leading tech-enabled platform for healthcare staffing backed…
High-Pressure Contrast Media Injectors Market to grow by USD 113.21 by 2026
The “High-Pressure Contrast Media Injectors Market – Competitive Analysis, Challenges, Drivers & Five Force Analysis” report has…
Mobile Cardiac Telemetry Systems Market to grow by USD 424.19 million
The “Mobile Cardiac Telemetry Systems Market – Competitive Analysis, Drivers, Challenges & Five Force Analysis” report…
Pharmacy Groups: CMS Guidance Sets Up Oral Antivirals for Failure, Limiting Patients’ Access to COVID-19 Treatments
A group of six pharmacy organizations today criticized the decision of the U.S. Centers for Medicare…
Amcor Unveils State-of-the-art Healthcare Packaging Facility In Singapore To Serve Accelerating Customer Demands In Asia Pacific
Amcor (NYSE: AMCR) (ASX:AMC), a global leader in developing and producing responsible packaging, today announced the opening…
CTI BioPharma Announces Extension of FDA Review Period for Pacritinib in Myelofibrosis with Severe Thrombocytopenia
CTI BioPharma Corp. (Nasdaq: CTIC) today announced the U.S. Food and Drug Administration (FDA) has extended the…
Another Strong Exit for HealthEdge Investment Partners with Sale of The Columbus Organization to CareSource
HealthEdge Investment Partners (“HealthEdge”), a Tampa-FL based private equity fund focused on lower middle market healthcare companies, continues…
nference Study Produces First Molecular Hypothesis Explaining COVID-19-Induced Myocarditis
nference, the AI-driven health technology company, today announced publication of a preprint study in bioRxiv that found the…
Aditum Bio announces the appointment of Stephen Kanes, M.D. Ph.D., as Chief Executive Officer of Ancora Bio
Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis CEO Joe Jimenez and former President…